Antlia Bioscience, Inc. funding

Antlia Bioscience, Inc., a biotechnology company based in Encinitas, CA, filed a Form D with the SEC on June 5, 2026 and reported $6M raised of a $20M offering.

Amount raised$6M

Offering size$20M

Filed with the SECJune 5, 2026

First saleMay 22, 2026

IndustryBiotechnology

SecuritiesEquity

LocationEncinitas, CA

FoundedMore than 5 years ago

Entity typeCorporation

Investors so far3

Minimum investment—

Revenue rangeDecline to Disclose

View the original Form D on SEC EDGAR ↗ · All rounds filed Jun 5

Other health care rounds in California

Alpfa Medical, Inc.$80.3M · Sep 28Other Health Care BigHat Biosciences, Inc.$75.1M · Oct 26Biotechnology Caspian Therapeutics, Inc.$50M · Sep 23Biotechnology Estuary Biotherapeutics, Inc.$40.7M · Oct 16Biotechnology PFARADIGM Health, Inc.$31.1M · Sep 28Other Health Care Trellis Bioscience, Inc.$22.9M · Oct 21Biotechnology Altay Therapeutics, Inc.$15.7M · Oct 2Biotechnology Adela, Inc.$12M · Oct 19Biotechnology